Navigation Links
Columbia study shows widely used artery clearing device does not help patients during heart attack

Interventional cardiologists from Columbia University Medical Center have shown that a commonly used procedure to remove fatty debris from blocked arteries during a heart attack does not improve patient outcomes.

The procedure, called distal microcirculatory protection, is commonly and successfully used during angioplasty in vein grafts and stenting in carotid arteries. The study, published in the March 2 issue of the Journal of the American Medical Association, found that the devices were successful in removing debris from the arteries in angioplasties during heart attacks, but it showed that there was no benefit to the patient.

"It's not entirely clear why the devices failed to improve patient outcomes, but it's possible that so much damage happens during a heart attack that distal protection is simply too little, too late," said Gregg W. Stone, M.D., director of research and education for the Center for Interventional Vascular Therapy at Columbia University Medical Center and New York-Presbyterian Hospital, and vice chairman of the Cardiovascular Research Foundation.

The study, which was conducted in 38 institutions in seven countries, examined 501 patients who were having heart attacks, half of whom received distal protection.

During angioplasty procedures, fatty deposits in the arteries can be dislodged and clog arteries further downstream. Distal protection devices use a specialized guidewire and catheter to collect and remove this debris.

The study evaluated the efficacy of distal protection devices using several measures, including evaluating patient ST segments ?a portion of the EKG that can indicate heart damage when it is elevated. The study showed that the percentage of patients who had normalization of the ST segment were the same, whether or not distal protection devices were used.

Within six months of the heart attack, patients had a comparable frequency of major adverse cardiac events regardless of wheth
'"/>

Source:Columbia University Medical Center


Page: 1 2

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. Columbia scientists develop cancer terminator viruses
3. Contaminants linked to sturgeon decline in Columbia river
4. Columbia University licenses next-generation DNA sequencing technology
5. New bird discovered on unexplored Columbian mountain
6. Columbia scientists determine 3-dimensional structure of cells fuel gauge
7. Bioartificial kidney under study at MCG
8. W.M. Keck Foundation funds study of friendly microbes
9. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
10. Genome-wide mouse study yields link to human leukemia
11. Clam embryo study shows pollutant mixture adversely affects nerve cell development

Post Your Comments:
(Date:11/23/2009)...s available in German . , A bit of imaginat... be a bad thing. It could help to add data from ar...ever, it must do so constructively. In order to in...th more than just imagination, physicists at the M...ed a theory of spatial perception called informati...
(Date:11/23/2009)...s available in German . , Not just birds, b...every year. Researchers at Princeton University in...thology in Radolfzell, Germany studied the migrato... the so-called "Vespertilionidae" with the help of...ration over short as well as long distances of var...
(Date:11/22/2009)...hildren exposed prenatally to tobacco smoke and du...sk for ADHD, according to research done at Cincinn...udy estimates that up to 35 percent of ADHD cases ...reduced by eliminating both of these environmental...0 children , "Tobacco and lead exposure each ha...
Breaking Biology News(10 mins):Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4We're off then: The evolution of bat migration 2Exposure to lead, tobacco smoke raises risk of ADHD 2AMD LASERS Announces the Addition of Bart Waclawik New Chief Operating Officer 6290 1AMD LASERS Announces the Addition of Bart Waclawik New Chief Operating Officer 6290 2Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 1Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 2Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 3Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 4Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 5Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 6Shire Announces Publication of Open Label Study on Coadministration of INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets with Stimulants 6285 7Child Food Allergies on the Rise in U S 61410 1Child Food Allergies on the Rise in U S 61410 2Child Food Allergies on the Rise in U S 61410 3
...New evidence from a study of yeast cells has resul...evolutionary process to date, says a Texas A&M Uni...ngs provide the first direct evidence of aspects, ...orking with populations of yeast cells, which were...istant professor in the Artie McFerrin Department ...
...Today, a new, international competition called the... leading research agencies: the Joint Information ...the National Endowment for the Humanities (NEH) an...nited States, and the Social Sciences and Humaniti...Digging into Data Challenge encourages humanities ...
... VIRGINIA KEY, Fla. -- An international team of sc...ine chemists for decades. They have discovered tha...eans, calcium carbonate production, which affects ...es a conservative estimate of three to 15 percent ..., but the researchers believe it could be up to th...
Other Biology News:Evolutionary process more detailed than previously believed, study shows 2Evolutionary process more detailed than previously believed, study shows 3Evolutionary process more detailed than previously believed, study shows 4Leading research agencies announce new international competition: "The digging into data challenge" 2Fishdunnit! Mystery solved 2Fishdunnit! Mystery solved 3
(Date:11/24/2009)...cacyendpointhasbeenmetforpatientswithadvanced-stag...Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(N...maceuticalcompanyfocusedonendocrinetherapyandoncol...tudywithitstargetedcytotoxicpeptideconjugate,AEZS-...entendometrialcancer.Inapersonalizedhealthcareappr...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHealt...GenomicHealth,sExecutiveChairman,willpresentatthe2...CityonTuesday,December1,2009at10:00a.m.ET. ,, T...resentation,visittheInvestorRelationssectionofGeno....com .Pleaseconnecttothewebsiteatleast15minutespri...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(C...stAnnualPiperJaffrayHealthCareConference.Theconfer...otel. ,, CTIwillpresentonTuesday,December1at11:...castofCTI,spresentationwillbeavailableat www.cellt...afterwards. , ,PiperJaffrayHealthCareConference,N...
(Date:11/23/2009)... of a two-dimensional carbon layer in which the ca...sembling a honeycomb. Carbon nanotubes are rolled-... sheets form graphite. Graphene boasts some very s...tant, an excellent thermal conductor, and reconcil...uctility. In addition, graphene is impermeable to ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
... for 5:00 p.m. ET , , ORANGE COUNTY, Calif., Apri...ed today it will host a conference call on Tuesday...ompany,s first quarter 2009 results. Earnings wil... http://www.newscom.com/cgi-bin/prnh/20031202/BE...877) 516-3365 or (706) 679-3246 and asking for the...
...How can outsourcing partners produce win-win resul...DO is pleased to offer a free educational Webinar ...ogies (PAT) to improve project communication and p... partners and their sponsors. , ...TLER TOLEDO invites you to a free webinar, Proces...
...lone Program for the Treatment of Epilepsy , , BR...Inc., a developer of drugs to treat serious neurol...the close of a $20 million Series B financing. The...t announcement of positive Phase 2a data for ganax...ial onset seizures. The Series B financing include...
Other Biology Technology:Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes 2Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing 2Marinus Pharmaceuticals Raises $20 Million in Series B Financing 2Marinus Pharmaceuticals Raises $20 Million in Series B Financing 3Marinus Pharmaceuticals Raises $20 Million in Series B Financing 4Marinus Pharmaceuticals Raises $20 Million in Series B Financing 5
Human BMP 2 ELISA construction Kit from Antigenix America Inc.
Rabbit Anti-Ferret Whole Serum Polyclonal Antibody, Unconjugated from Bethyl Laboratories
...roprietary Focus™ detector technology, while...e R4. The microPET Focus 120 offers the highest s...r. Focus scanners also possess the highest spatia... The combination of high resolution and senistivit...
GST Expression and Purification Kit from BD Biosciences Pharmingen
Biology Products: